No recent analyst price targets found for KTYCF.
Latest News for KTYCF
Kits Eyecare Q2 Earnings Call Highlights
Kits Eyecare TSE: KITS reported second-quarter 2026 revenue growth of 17.8% year over year as its prescription-glasses business expanded and repeat customers contributed a larger share of sales. The company also posted net income, record operating cash flow and its 15th consecutive quarter of positive adjusted EBITDA.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for KTYCF.
Senate Trading
No Senate trades found for KTYCF.
U.S. House Trading
No House trades found for KTYCF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.